Featured Research

from universities, journals, and other organizations

Visual alerts shown to evoke quicker reactions than alerts through other senses

Date:
February 27, 2012
Source:
IOS Press
Summary:
New research has shown that visual alerting methods are still considered to be the most trustworthy, as compared to auditory or tactile alerts.

New research has shown that visual alerting methods are still considered to be the most trustworthy, as compared to auditory or tactile alerts. This is shown by research conducted by a team of scientists at Old Dominion University in Norfolk, VA, USA.

The research Alert Characteristics and Identification of Avatars on a Virtual Battlefield by James P. Bliss, Rachel Liebman and J. Christopher Brill is published in the current issue (6:2) of the journal Intelligent Decision Technologies.

Most research to date has been limited to the visual or auditory signal modality. The question of how signal reliability interacts with signal modality to impact reaction behaviors is important with regard to applied environments such as the military battlefield.

In the study, thirty undergraduate students completed two sessions of a virtual reconnaissance mission. During each session, they received ten alerts about nearly opposing forces. They indicated trust or distrust of each alert, and subsequently identified the avatar as friend or foe. Results indicated that participants trusted more historically reliable alerts, and that they showed quicker identification behaviour for visually presented alerts.


Story Source:

The above story is based on materials provided by IOS Press. Note: Materials may be edited for content and length.


Cite This Page:

IOS Press. "Visual alerts shown to evoke quicker reactions than alerts through other senses." ScienceDaily. ScienceDaily, 27 February 2012. <www.sciencedaily.com/releases/2012/02/120227111425.htm>.
IOS Press. (2012, February 27). Visual alerts shown to evoke quicker reactions than alerts through other senses. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/02/120227111425.htm
IOS Press. "Visual alerts shown to evoke quicker reactions than alerts through other senses." ScienceDaily. www.sciencedaily.com/releases/2012/02/120227111425.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins